Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance
|
|
- Muriel Moody
- 6 years ago
- Views:
Transcription
1 Anatomic Pathology / AUS Qualifiers in Thyroid FNAs Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance Paul A. VanderLaan, MD, PhD, 1 Ellen Marqusee, MD, 2 and Jeffrey F. Krane, MD, PhD 1 Key Words: Thyroid; Fine-needle aspiration; Cytology; Atypia of undetermined significance Abstract The diagnostic category of atypia of undetermined significance (AUS) in the Bethesda System for reporting the results of thyroid fine-needle aspirations (FNAs) is intended to encompass findings associated with a low risk of malignancy. It is unclear if there are patterns within this evolving, heterogeneous category associated with differing risk of malignancy that might warrant alternative classification or clinical management. Therefore, a retrospective review of 512 AUS FNAs from January 2005 to May 2009 was done. Most malignancies associated with AUS were papillary carcinoma (86/96 [90%]), of which 85% (73/86) were follicular variants. Atypia qualifiers were correlated with the follow-up rate of malignancy. The risk of malignancy for architectural atypia alone was approximately half that observed for cytologic, both cytologic and architectural, or unspecified atypia. Architectural atypia alone was less likely to be papillary carcinoma and more likely to be follicular adenoma. The lower risk of malignancy associated with isolated architectural atypia compared with other patterns of AUS should be considered in clinical decision making and in future management guidelines. Thyroid nodule fine-needle aspiration (FNA) has proven to be a reliable, relatively noninvasive method for determining the risk of malignancy of a thyroid nodule, thereby identifying patients most appropriately referred for surgery. The recently proposed reporting schema for thyroid FNAs, born out of the 2007 National Cancer Institute (NCI) Thyroid Fine Needle Aspiration State of the Science Conference 1,2 with the subsequent Bethesda System for Reporting Thyroid Cytopathology, 3 provides a uniform 6-tiered diagnostic framework for classifying thyroid nodule FNAs based on malignancy risk from multiple studies. The category known as atypia of undetermined significance (AUS), or follicular lesion of undetermined significance, is composed of a heterogeneous mix of diagnostic scenarios that are indeterminate but anticipated to have a low risk of malignancy. A number of recent studies have investigated the biologic behavior of thyroid nodules with an AUS diagnosis based on clinical and surgical follow-up data, 4-13 with an observed risk of malignancy ranging from 5% to 48%. This wide range of risk may be partly attributable to the heterogeneous nature of the AUS category, and it remains to be seen if there are particular specimen characteristics that are more strongly associated with malignancy. To this end, we report a retrospective analysis of thyroid FNAs with a diagnosis of AUS with their associated outcome data to determine if any salient diagnostic features exist that could better stratify the subsequent risk of malignancy. Materials and Methods After receiving approval from the institutional review board, a retrospective analysis was conducted of the 4, Am J Clin Pathol 2011;136: Downloaded 572 from
2 Anatomic Pathology / Original Article thyroid FNAs performed at Brigham and Women s Hospital, Boston, MA, from January 2005 to May All FNAs were performed by staff endocrinologists using a 25-gauge needle with ultrasound guidance (typically 3-4 passes). The specimen was collected immediately in CytoLyt (Hologic, Marlborough, MA), and Papanicolaou-stained ThinPrep slides were prepared using the ThinPrep 2000 (Hologic). Rapid on-site evaluation with direct smear preparation was not performed routinely. All cases were reported by a staff cytopathologist using a 6-tiered diagnostic system with diagnostic criteria essentially identical to those of the 2007 National Cancer Institute Thyroid FNA State of the Science Conference guidelines 1,2 and the Bethesda System for Reporting Thyroid Cytopathology. 3 Since adopting a 6-tiered diagnostic system, pathologists in our laboratory have been encouraged, but not required, to use brief descriptive language to characterize the nature of the atypia when reporting an AUS diagnosis. Descriptors of cytologic atypia, architectural atypia, or both cytologic and architectural atypia have been used to broadly describe the atypia, but without providing details (such as rare intranuclear pseudoinclusions) that could be misconstrued clinically as representing a more severe diagnosis (such as suggestive of papillary carcinoma). Representative images of these qualifiers of AUS are shown in Image 1. AUS with architectural atypia encompasses focal or mild features similar to but not sufficient for a diagnosis of A B C D Image 1 A, Architectural atypia: rare microfollicular groups present in an otherwise hypocellular specimen (Papanicolaou, 400). B, Cytologic atypia: occasional group of follicular cells with mild cytologic changes including few nuclear grooves, powdery chromatin, and the presence of small distinct nucleoli (Papanicolaou, 1,000). C, Cytologic and architectural atypia: rare clusters of follicular cells with a combination of mild cytologic changes and microfollicular architecture (Papanicolaou, 1,000). D, Atypia unspecified: follicular cells with mild nuclear crowding and enlargement with slightly pale chromatin (Papanicolaou, 600). Downloaded from Am J Clin Pathol 2011;136:
3 VanderLaan et al / AUS Qualifiers in Thyroid FNAs suspicious for a follicular neoplasm. This would include a predominance of microfollicles in a sparsely cellular specimen or focal crowding/disorder of follicular cells (not attributable to preparation artifact) in the absence of associated nuclear changes. AUS with cytologic atypia is broadly regarded as a specimen with features similar to but not sufficient for a diagnosis of suspicious for papillary thyroid carcinoma or malignant. Here, the cytologic/nuclear features of papillary thyroid carcinoma (nuclear grooves, powdery chromatin, nuclear membrane thickening/irregularity, nuclear molding/ crowding, and rarely nuclear pseudoinclusions) would be present in a small number of cells in a paucicellular or normocellular specimen, or, alternatively, the changes could be mild but more widespread. The diagnosis of AUS with both cytologic and architectural atypia applies to cases with a combination of characteristics from the cytologic and architectural subcategories. A diagnosis of AUS without a cytologic or architectural atypia qualifier could be given for cases including an atypical lymphocytic infiltrate, Hürthle cell change deemed insufficient for a suspicious diagnosis or in a clinical context in which a neoplasm is less probable (such as a goiter or Hashimoto thyroiditis), or atypia complicated by obscuring blood or other technical artifacts. Unqualified AUS could also represent the failure of the responsible cytopathologist to attempt to classify the atypia into the architectural or cytologic category. Additional diagnostic descriptors provided in the original report were also evaluated. These descriptors included a qualitative assessment of the severity of atypia present (eg, mild atypia); the overall cellularity of the specimen (eg, scantly cellular); the qualitative number of atypical cells present (eg, rare atypical cells); and the presence of colloid, histiocytes, hemosiderin-laden macrophages, cyst lining cells, or Hürthle cell changes. The AUS cases compiled were not rereviewed or reclassified retrospectively by us, reflecting the actual use of these atypia qualifiers and additional descriptors in everyday practice. Clinical outcome for the aspirated thyroid nodule was categorized as benign or malignant. A benign outcome was defined as a benign cytologic diagnosis made on followup FNA or a tissue diagnosis of multinodular hyperplasia, follicular adenoma, adenomatous nodule, Hashimoto thyroiditis, or incidental papillary thyroid microcarcinoma (not associated with the targeted FNA nodule) on histologic evaluation. Outcomes were classified as malignant when a histologic diagnosis of malignancy was made on resection of the aspirated nodule. When evaluating the surgical resection specimen, only the target nodule was considered and correlated with the preceding FNA findings. All cases had at least 1 year of clinical follow-up after the initial AUS thyroid FNA. Data processing and statistics were performed by using Microsoft Excel (Microsoft, Redmond, WA) and GraphPad software (GraphPad Software, La Jolla, CA). Categorical analysis was performed by using a 2-tailed χ 2 test or a 2-tailed Fisher exact test when appropriate, with a predetermined level of significance set at a P value of.05. Results Overall outcome data for this cohort have been published elsewhere. 13 Briefly, a diagnosis of AUS was given in 512 cases (10.9%): 99 males and 413 females, mean age, 53 years (range, 9-88 years). From this cohort, 63 (12.3%) were repeated AUS diagnoses for the same thyroid nodule and 118 (23.0%) had incomplete or no further follow-up on record. A total of 199 (38.9%) cases underwent surgical resection. Taken together with cases having a benign repeated FNA, a total of 331 thyroid nodules with an initial FNA diagnosis of AUS had clinical follow-up data available. Based on overall outcome data, 96 nodules were malignant (29.0%), whereas 235 nodules were benign (71.0%). Outcome data were initially stratified by atypia qualifier including benign cytologic follow-up and histologic outcome Table 1. Architectural atypia alone had a malignant outcome (11/70 [16%]) nearly half as frequently as the other qualifier Table 1 Cytologic and Histologic Outcome Data for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Based on Atypia Qualifier * Atypia Qualifier Benign Malignant Total Architectural 84 (59/70) 16 (11/70) 21.1 (70/331) Cytologic 71 (42/59) 29 (17/59) 17.8 (59/331) Cytologic and architectural 72 (60/83) 28 (23/83) 25.1 (83/331) Unspecified 62.2 (74/119) 37.8 (45/119) 36.0 (119/331) All nonarchitectural atypia 67.4 (176/261) 32.6 (85/261) 78.9 (261/331) Total 71.0 (235/331) 29.0 (96/331) 100 (331/331) * Data are given as percentage (number/total) of cases. Architectural atypia vs atypia unspecified, P <.002. Architectural atypia vs all nonarchitectural atypia, P = Am J Clin Pathol 2011;136: Downloaded 574 from
4 Anatomic Pathology / Original Article Table 2 Surgical Outcome Data for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Based on Atypia Qualifier * Atypia Qualifier Benign Malignant Total Architectural 76 (34/45) 24 (11/45) 22.6 (45/199) Cytologic 50 (17/34) 50 (17/34) 17.1 (34/199) Cytologic and architectural 54 (27/50) 46 (23/50) 25.1 (50/199) Unspecified 36 (25/70) 64 (45/70) 35.2 (70/199) Total 51.6 (103/199) 48.2 (96/199) (199/199) * Data are given as percentage (number/total) of cases. Architectural atypia vs cytologic atypia, P <.04. Architectural atypia vs cytologic and architectural atypia, P <.04. Architectural atypia vs atypia unspecified, P = categories: cytologic atypia alone (17/59 [29%]), architectural and cytologic atypia (23/83 [28%]), and atypia unspecified (45/119 [37.8%]). Statistical significance was achieved when comparing architectural atypia alone with the total of the rest of the groups (P =.005) and architectural atypia compared with atypia unspecified (P <.002). No other differences between groups achieved statistical significance. Table 3 Specific Histologic Diagnoses Based on Atypia Qualifier Atypia Qualifier/Diagnosis No. (%) Architectural Benign 34 (100) Adenoma 23 (68) MNH 9 (26) HASH 2 (6) Malignant 11 (100) PTC 11 (100) Cytologic * Benign 17 (100) Adenoma 9 (53) MNH 8 (47) Malignant 17 (100) PTC 17 (100) Cytologic and architectural Benign 27 (100) Adenoma 23 (85) MNH 4 (15) Malignant 23 (100) PTC 20 (87) FTC 3 (13) Unclassified Benign 25 (100) Adenoma 14 (56) MNH 10 (40) HASH 1 (4) Malignant 45 (100) PTC 38 (84) FTC 5 (11) ANA 1 (2) DLBCL 1 (2) ANA, anaplastic (undifferentiated) thyroid carcinoma; DLBCL, diffuse large B-cell lymphoma; FTC, follicular thyroid carcinoma; HASH, chronic lymphocytic thyroiditis (Hashimoto thyroiditis); MNH, multinodular hyperplasia; PTC, papillary thyroid carcinoma. * Architectural atypia vs cytologic atypia: PTC vs all other diagnoses, P <.04; adenoma vs all other diagnoses, P <.04; benign follicular nodule (adenoma + MNH) vs all other diagnoses, P <.07, not significant. Architectural atypia vs unclassified atypia: PTC vs all other diagnoses, P =.002; adenoma vs all other diagnoses, P =.0009; benign follicular nodule (adenoma + MNH) vs all other diagnoses, P = Recent studies suggest that benign cytologic follow-up alone may not have significance equivalent to that of benign histologic outcome. 13,14 Therefore, we also evaluated clinical outcome data using surgical pathology diagnoses alone as the gold standard Table 2. Once again, architectural atypia alone had a malignant outcome (11/45 [24%]) roughly half that of all other qualifiers with a statistically significant difference observed from cytologic atypia alone (17/34 [50%]; P <.04), cytologic and architectural atypia (23/50 [46%]; P <.04), and unspecified atypia (45/70 [64%]; P =.0001). To further characterize outcome differences, we compared the histologic diagnoses among AUS qualifiers Table 3. The category of architectural atypia alone exhibited statistically significant differences from the cytologic atypia alone and unqualified atypia categories. The architectural atypia alone qualifier was less likely to be papillary carcinoma and more likely to be an adenoma. The 96 malignant diagnoses included 86 papillary carcinomas (90%), 8 follicular carcinomas (9%), and 1 case each of undifferentiated carcinoma and diffuse large B-cell lymphoma. The small number of follicular carcinomas identified belonged to the cytologic and architectural atypia and unqualified atypia categories and not to the architectural atypia alone group. The follicular variant comprised the majority of the papillary carcinomas (73/86 [85%]) with no statistically significant difference in subtype of papillary carcinoma among the AUS qualifiers (data not shown). To determine if any other specimen descriptors present in the report could predict malignancy, we evaluated outcome with respect to the severity of atypia present; the specimen cellularity; the qualitative number of atypical cells; and the presence of colloid, histiocytes, hemosiderin-laden macrophages, cyst lining cells, or Hürthle cell changes. No statistically significant difference in outcome was noted for any of these descriptors (data not shown). Discussion As defined by the Bethesda System, the atypia of undetermined significance category is heterogeneous with respect to inclusion criteria, intended to result in a Downloaded from Am J Clin Pathol 2011;136:
5 VanderLaan et al / AUS Qualifiers in Thyroid FNAs risk of malignancy intermediate between the benign and suspicious categories. This study represents an attempt to identify the diagnostic characteristics of cases within the AUS category that may predict a higher or lower risk of malignancy. Our results indicate that cases deemed atypical based solely on architectural atypia have nearly half the risk of malignancy as cases classified as cytologic atypia alone, as cases classified as cytologic and architectural atypia, and in cases in which the atypia is unclassified. Furthermore, on histologic follow-up, the AUS pattern of architectural atypia alone is more likely than the nonarchitectural atypia based patterns of AUS (cytologic atypia alone and unspecified atypia) to represent a follicular adenoma. Although no other diagnostic qualifiers examined were found to confer significantly different predictive risk, it is important to acknowledge that the present study was based on a retrospective review of primary pathology reports without performing a slide review. The subclassification of the atypia type and the inclusion of any other diagnostic features in the final report were at the discretion of the original cytopathologist, reflecting a real-world working experience with this diagnostic category. As such, the varying reporting practices of individual cytopathologists within our laboratory may have adversely affected the power of our study to detect the importance of the various qualifiers in AUS. Although others have reported some prognostic usefulness for associated findings in atypical thyroid FNA samples, 11 the lack of association seen in the present study may mean that these common findings (presence or absence of colloid, histiocytes, hemosiderin-laden macrophages, cyst lining cells, or Hürthle cell change) are not robustly associated with significant risk stratification or, alternatively, that any association that exists could not be readily identified within this study design. Despite these limitations, our findings are in keeping with limited previous reports suggesting that different subtypes of AUS specimens indeed vary with respect to the risk of malignancy. As shown herein, a thyroid nodule with a diagnosis of AUS with architectural atypia alone has a risk of malignancy of approximately 16%, which falls between that of the benign (2%-3%) and suspicious for a follicular neoplasm (20%-30%) categories. 1,2 Conversely, a diagnosis of AUS with a component of cytologic atypia (characterized as cytologic atypia alone or cytologic atypia accompanied by architectural atypia) has a malignancy risk closer to 30%. Therefore, one could conclude that there is a higher risk of malignancy when incomplete features of papillary carcinoma are present as opposed to features more likely to be associated with a follicular neoplasm. A recent study by Renshaw 9 reports a similar dichotomy for atypical thyroid aspirates with histologic follow-up. In cases diagnosed as atypical, rule out papillary carcinoma, a malignant outcome was found in 38% of cases, whereas in cases diagnosed as atypical, rule out follicular neoplasm, a malignant outcome was found in 22% of cases, approximately half as frequently. Another study has also shown that focal features of papillary carcinoma in thyroid aspirates categorized as atypical were strongly associated with a malignancy at subsequent surgical resection. 15 Thus, it seems clear that the identification of rare or incomplete nuclear/cytologic features of papillary carcinoma has a risk of malignancy higher than the identification of architectural atypia alone. In our study population, a large majority of the malignancies identified in association with AUS were papillary carcinoma (86/96 [90%]), and most of these were follicular variants (73/86 [85%]). These findings suggest that the lesser degrees of atypia identified in an AUS FNA sample may preferentially correlate with detection of the controversial 16 and commonly less aggressive follicular variant of papillary carcinoma when compared with a suspicious or positive diagnosis. It is not surprising that architectural atypia alone would be less predictive of identifying papillary carcinoma. Perhaps more surprising is that although architectural atypia alone was associated with the presence of a benign follicularpatterned nodule, none of the few follicular carcinomas in our population were associated with the pattern of architectural atypia alone. The lack of association between follicular carcinoma and AUS with architectural atypia may reflect a fundamental difference in this pattern relative to the suspicious for follicular neoplasm category, but could also be because of the low overall prevalence of follicular carcinoma in this study. The management of a given thyroid nodule following an AUS diagnosis is dictated by the anticipated risk of malignancy, and there seems to be mounting evidence from multiple laboratories that AUS has a risk of malignancy higher than originally predicted This finding may translate into a more aggressive management algorithm by clinicians as familiarity with this diagnostic category builds. If, however, most of the carcinomas detected with AUS are follicular variants of papillary carcinoma, as was the case in our study, an argument could be made that aggressive management may not be warranted for this typically indolent entity. The wide range of malignancy risk reported by authors from different laboratories in association with AUS speaks to the heterogeneity of lesions for which this diagnosis is used on FNA, but may also reflect variation in the diagnostic threshold for the follicular variant of papillary carcinoma in surgical pathology. With the appropriate management for AUS unresolved, identification of lesions with differing risks of malignancy may be valuable in guiding clinical decision making. Our findings support the continued use of AUS for cases in which isolated architectural atypia is present because these 576 Am J Clin Pathol 2011;136: Downloaded 576 from
6 Anatomic Pathology / Original Article aspirates have the low risk of malignancy envisioned for the AUS category when the Bethesda System was implemented. Conversely, evidence continues to accumulate indicating that AUS with focal features of papillary carcinoma or cytologic atypia has a malignancy risk that, although lower than for a diagnosis of suspicious for papillary carcinoma, is higher than had been anticipated for the AUS category in the initial implementation of the Bethesda System. Further study is warranted to determine how or if focal features of papillary carcinoma can be reproducibly and meaningfully separated from the suspicious for papillary carcinoma category. The AUS diagnostic category as it is currently defined is heterogeneous with respect to inclusion criteria and the estimated risk of malignancy for different lesions. Our study and the studies of others support the notion that architectural atypia alone has a much lower risk of malignancy than focal atypia related to traditional cytologic features of papillary carcinoma. Further experience is needed to establish the risk of malignancy associated with other less common patterns of AUS. Although the practice of using diagnostic qualifiers of AUS is not dictated by the Bethesda System, we favor this practice to facilitate further refinement of this diagnostic category with the aim of providing better risk stratification and clinical management for AUS aspirates. From the Departments of 1 Pathology and 2 Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA. Address reprint requests to Dr Krane: Cytopathology Division, Head and Neck Pathology Service, Dept of Pathology, Brigham and Women s Hospital, 75 Francis St, Boston, MA References 1. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a summation. Cytojournal. 2008;5:6. 2. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132: Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. New York, NY: Springer; Nayar R, Ivanovic M. The indeterminate thyroid fineneedle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer. 2009;117: Layfield LJ, Morton MJ, Cramer HM, et al. Implications of the proposed thyroid fine-needle aspiration category of follicular lesion of undetermined significance : a five-year multi-institutional analysis. Diagn Cytopathol. 2009;37: Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda Thyroid Fine-Needle Aspiration Classification System: year 1 at an academic institution. Thyroid. 2009;19: Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer. 2009;117: Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010;38: Renshaw AA. Should atypical follicular cells in thyroid fine-needle aspirates be subclassified [published correction appears in Cancer Cytopathol. 2010;118:303]? Cancer Cytopathol. 2010;118: Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fineneedle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2010;134: Somma J, Schlecht NF, Fink D, et al. Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol. 2010;54: Marchevsky AM, Walts AE, Bose S, et al. Evidencebased evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol. 2010;38: VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fineneedle aspirations: should repeat FNA be the preferred initial approach? Am J Clin Pathol. 2011;135: Renshaw AA. Does a repeated benign aspirate change the risk of malignancy after an initial atypical thyroid fine-needle aspiration? Am J Clin Pathol. 2010;134: Weber D, Brainard J, Chen L. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol. 2008;52: Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008;130: Downloaded from Am J Clin Pathol 2011;136:
Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
Anatomic Pathology / Clinical Outcome for AUS Thyroid FNA Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
More informationDIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION
Follicular-patterned thyroid lesions, WC Faquin 1 DIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION William C. Faquin, M.D., Ph.D Department of Pathology, Massachusetts
More informationThyroid Cytopathology: Weighing In The Bethesda System
Thyroid Cytopathology: Weighing In The Bethesda System V8 Conflicts No financial consideration Bias Work in the Canadian environment where litigation is less Thyroid cytology is often referred in by small
More informationPredictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases
Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases Can Potential Clues of Malignancy Be Identified? Mohammad Jaragh, MD 1 ; V. Bessie Carydis, MMedSci (Cytol) 1 ; Christina
More informationsystem and the Bethesda system applied for reporting thyroid cytopathology
Original Research Article A comparative study between conventional system and the Bethesda system applied for reporting thyroid cytopathology M. Mamatha 1*, S. Chandra Sekhar 2, H. Sandhya Rani 3, S. Sandhya
More informationThyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS
Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Attending Pathologist Rhode Island Hospital, Providence, RI DISCLOSURE:
More informationKyle C. Strickland, MD, PhD; Brooke E. Howitt, MD; Justine A. Barletta, MD; Edmund S. Cibas, MD Jeffrey F. Krane, MD, PhD
Suggesting the Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): A Retrospective Analysis of Atypical and Suspicious Nodules Kyle C. Strickland,
More informationPotential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma:
SUPPLEMENT 1 SPECIAL ISSUE: CYTOPATHOLOGY OF THE THYROID GLAND Guest Editor: Zubair Baloch Potential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma: A Cytohistologic Review of 22 Cases Xin
More informationBackground to the Thyroid Nodule
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital THYROID FNA: PART I Background to the
More informationCytopathological evaluation of various thyroid lesions based on Bethesda system for reporting thyroid lesions
International Journal of Research in Medical Sciences Khadatkar AS et al. Int J Res Med Sci. 2017 Apr;5(4):1339-1343 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170901
More informationCase #1. Ed Stelow, MD University of Virginia
Case #1 Ed Stelow, MD University of Virginia Imagine, If You Will It s 4:30 on Friday Last cytology case A thyroid FNA from outside that did not have any onsite interpretation It is from a 45-year old
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationCytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Case Study
More information3/22/2017. Disclosure of Relevant Financial Relationships. Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Disclosure
More informationThyroid master class. Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson
Thyroid master class Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson Principle of LBC Collection of cells in liquid medium Immediate fixation Processor-prepared
More informationNCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology
The Bethesda System For Reporting Thyroid Cytopathology Towards a Uniform Terminology With Management Guidelines NCI Thyroid FNA State of the Science Conference Bethesda, MD October 22-23, 2007 154 registrants
More informationComparison of Thyroid Fine-Needle Aspiration and Core Needle Biopsy
Anatomic Pathology / THYROID FNA AND CORE NEEDLE BIOPSY Comparison of Thyroid Fine-Needle Aspiration and Core Needle Biopsy Andrew A. Renshaw, MD, 1 and Nat Pinnar, MD 2 Key Words: Thyroid; Neoplasia;
More informationFNA of Thyroid. Toward a Uniform Terminology With Management Guidelines. NCI NCI Thyroid FNA State of the Science Conference
FNA of Thyroid NCI NCI Thyroid FNA State of the Science Conference Toward a Uniform Terminology With Management Guidelines Thyroid Thyroid FNA Cytomorphology NCI Thyroid FNA State of the Science Conference
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Validity Assessment of The Bethesda System for Reporting Thyroid Cytopathology Ranjana Solanki
More information"Atypical": Criteria and
"Atypical": Criteria and Controversies Esther Rossi MD PhD MIAC Division of Anatomic Pathology and Cytology Catholic University of Sacred Heart Rome, Italy CASE HISTORY In 2015, 45 y/o woman underwent
More informationRates of thyroid malignancy by FNA diagnostic category
Williams et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:61 ORIGINAL RESEARCH ARTICLE Open Access Rates of thyroid malignancy by diagnostic category Blair A Williams 1*, Martin J Bullock
More informationUpdate in Thyroid Fine Needle Aspiration
Endocr Pathol (2011) 22:178 183 DOI 10.1007/s12022-011-9182-7 Update in Thyroid Fine Needle Aspiration William C. Faquin & Massimo Bongiovanni & Peter M. Sadow Published online: 14 October 2011 # Springer
More informationThe Indeterminate Thyroid Fine-Needle Aspiration
The Indeterminate Thyroid Fine-Needle Aspiration Experience From an Academic Center Using Terminology Similar to That Proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State
More informationThe Atypical Thyroid Fine-Needle Aspiration: Past, Present, and Future
The Atypical Thyroid Fine-Needle Aspiration: Past, Present, and Future Massimo Bongiovanni, MD 1 ; Jeffrey F. Krane, MD, PhD 2 ; Edmund S. Cibas, MD 2 ; and William C. Faquin, MD, PhD 3 Thyroid fine-needle
More informationClinical Study Diagnosis of Follicular Lesions of Undetermined Significance in Fine-Needle Aspirations of Thyroid Nodules
Thyroid Research Volume 2013, Article ID 250347, 6 pages http://dx.doi.org/10.1155/2013/250347 Clinical Study Diagnosis of Follicular Lesions of Undetermined Significance in Fine-Needle Aspirations of
More informationIntroduction 10/27/2011. Follicular Lesion/Atypia of Undetermined Significance
Follicular Lesion/Atypia of Undetermined Significance Tarik M. Elsheikh, MD Cleveland Clinic Cleveland, Ohio Diagnostic Categories Proposed by Bethesda System/NCI Thyroid Conference 1. Benign 2. Follicular
More informationTHYROID CYTOLOGY THYROID CYTOLOGY FINE-NEEDLE-ASPIRATION ANCILLARY TESTS IN THYROID FNA
ANCILLARY TESTS IN THYROID FNA Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular Pathology Unit, IPATIMUP General-Secretary of the International
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationThe Frozen Section: Diagnostic Challenges and Pitfalls
The Frozen Section: Diagnostic Challenges and Pitfalls William C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Harvard Medical
More informationCytology for the Endocrinologist. Nicole Massoll M.D
Cytology for the Endocrinologist Nicole Massoll M.D Objectives Discuss slide preperation Definitions of adequacy ROSE (Rapid On-Site Evaluation) Thyroid Cytology Adequacy Nicole Massoll M.D. University
More informationXIII CONGRESSO NAZIONALE Roma, 7-9 novembre NODULO TIROIDEO: Agoaspirato o Core Needle Biopsy?
XIII CONGRESSO NAZIONALE NODULO TIROIDEO: Agoaspirato o Core Needle Biopsy? Anna Crescenzi Policlinico Universitario Campus Bio-Medico Roma Indeterminate lesions are heterogeneous The gray zone CONSERVATIVE
More informationINTRODUCTION. Original Article. Jiyeon Hyeon, MD 1 ; Soomin Ahn, MD 1 ; Jung Hee Shin, MD, PhD 2 ; and Young Lyun Oh, MD, PhD 1
The Prediction of Malignant Risk in the Category Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance of the Bethesda System for Reporting Thyroid Cytopathology Using Subcategorization
More informationNIFTP Cytologic Aspects
NIFTP Cytologic Aspects William C. Faquin, MD PhD Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Boston, MA USA So, what is the story about FVPTC
More informationJournal of Diagnostic Pathology 2011 (6); 1: Leading Article
Leading Article Beyond the horizon of current thyroid cytology reporting in Sri Lanka... Lokuhetty MDS Thyroid enlargement is a commonly encountered clinical problem among Sri Lankan patients, be it diffuse
More informationBuilding On The Best A Review and Update on Bethesda Thyroid 2017
Building On The Best A Review and Update on Bethesda Thyroid 2017 Syed Z. Ali, MD, FRCPath, FIAC Professor of Pathology and Radiology The Johns Hopkins Hospital, Baltimore, Maryland USA TBSRTC Diagnostic
More informationThe Korean Journal of Cytopathology 15(1) : 60-64, 2004
15 1 The Korean Journal of Cytopathology 15(1) : 60-64, 2004 : INTRODUCTION Papillary carcinoma of the thyroid gland has for long been traditionally diagnosed on the basis of the characteristic papillary
More informationTBSRTC 1- Probabilistic approach and Relationship to Clinical Algorithms
The Benefits of a Uniform Reporting System for Thyroid Cytopathology BETHESDA REPORTING SYSTEM Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular
More informationInter-observer reproducibility using The Besthesda System for Reporting Thyroid Cytopathology (TBSRTC)
SHORT COMMUNICATION Inter-observer reproducibility in thyroid cytology reporting Inter-observer reproducibility using The Besthesda System for Reporting Thyroid Cytopathology (TBSRTC) Doshi Neena 1*, Jhabuawala
More informationCytological Evaluation of Thyroid Lesions Based on the Bethesda System.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-086.Volume 5, Issue 2 Ver. VII (December. 206), PP 2-7 www.iosrjournals.org Cytological Evaluation of Thyroid Lesions
More informationEnterprise Interest None
Enterprise Interest None Risk stratification of salivary gland lesions on cytology based on the proposed Milan System for reporting salivary gland cytopathology: A pilot study Kartik Viswanathan, M.D.,
More informationUltrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events
Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Sandrine Rorive, M.D., PhD. Erasme Hospital - Université Libre de Bruxelles (ULB) INTRODUCTION The assessment of thyroid nodules
More informationVolume 2 Issue ISSN
Volume 2 Issue 3 2012 ISSN 2250-0359 Correlation of fine needle aspiration and final histopathology in thyroid disease: a series of 702 patients managed in an endocrine surgical unit *Chandrasekaran Maharajan
More informationTHE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A TWO YEAR INSTITUTIONAL AUDIT
IJCRR Section: Healthcare Sci. Journal Impact Factor 4.016 Research Article THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A TWO YEAR INSTITUTIONAL AUDIT Salma Bhat 1, Nazia Bhat 1, Humaira Bashir
More informationThyroid FNA: Diagnosis, Challenges and Solutions. Disclosures
Thyroid FNA: Diagnosis, Challenges and Solutions Zubair W. Baloch, MD, PhD None Disclosures 1 Questions to Myself? Where We are Now? The Present 2 Reality Check There is More to How Thyroid Nodules are
More informationRE-AUDIT OF THYROID FNA USING THE THY GRADING SYSTEM AND HISTOLOGY AT SUNDERLAND ROYAL HOSPITAL, 2011
Audit: RE-AUDIT OF THYROID FNA USING THE THY GRADING SYSTEM AND HISTOLOGY AT SUNDERLAND ROYAL HOSPITAL, 2011 Auditors: Dr Lena Wilkinson SpR Histopathology Dr. Debra Milne Consultant Histocytopathologist
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Molecular Markers for Fine Needle Aspirates of Thyroid Nodules MP-065-MD-DE Medical Management Provider Notice Date: 10/15/2018;
More informationCase #1 FNA of nodule in left lobe of thyroid in 67 y.o. woman
Challenging Cases Manon Auger M.D., F.R.C.P. (C) Professor, Department of Pathology McGill University Director, Cytopathology Laboratory McGill University it Health Center Case #1 FNA of nodule in left
More informationAtypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/10.4174/astr.2014.86.3.109 Annals of Surgical Treatment and Research Atypia of undetermined significance on thyroid fine needle aspiration:
More informationCN 925/15 History. Microscopic Findings
CN 925/15 History 78 year old female. FNA indeterminate lesion right thyroid lobe. Previous THY1C (UK) Bethesda category 1 cyst fluid. Ultrasound showed part solid/cystic changes, indeterminate in nature
More informationClinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle Aspiration Biopsy
Ann Surg Oncol (2009) 16:3146 3153 DOI 10.1245/s10434-009-0666-3 ORIGINAL ARTICLE ENDOCRINE TUMORS Clinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle
More informationHow to Interpret Thyroid Fine-Needle Aspiration Biopsy Reports: A Guide for the Busy Radiologist in the Era of the Bethesda Classification System
Neuroradiology/Head and Neck Imaging Review Dhyani et al. How to Interpret FNAB Results of Thyroid Nodules Neuroradiology/Head and Neck Imaging Review Manish Dhyani 1 William Faquin 2 Carrie C. Lubitz
More informationMalignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
Journal Articles Donald and Barbara Zucker School of Medicine Academic Works 2014 Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS) A. S. Ho E. E. Sarti K. S. Jain H. J.
More informationDOWNLOAD ENTIRE DOCUMENT FROM
PREVIEW ONLY 1 Atlas on Bethesda system for reporting Thyroid Cytology PREVIEW ONLY 2 OVERVIEW 1. Indications and goal of thyroid FNA 2. Contraindications 3. Procurement of cell sample 4. Staining methods
More informationThe Bethesda System for Reporting Thyroid Cytopathology, Laila Khazai 11/4/17
The Bethesda System for Reporting Thyroid Cytopathology, 2017 Laila Khazai 11/4/17 In Summary No major changes for cytologists. The clinical team is faced with different risk of malignancies (ROM) associated
More informationThyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia
Thyroid follicular neoplasms in cytology Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia Lecture overview importance of FNAB in assessing thyroid lesions follicular
More informationThyroid Cytopathology: What s New and What s Old That We Don t All Agree on?
Thyroid Cytopathology: What s New and What s Old That We Don t All Agree on? RITU NAYAR, MD PROFESSOR & VICE CHAIR OF PATHOLOGY NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE DIRECTOR OF CYTOPATHOLOGY,
More informationClinical performance and utility of Afirma GEC in a community hospital practice
Clinical performance and utility of Afirma GEC in a community hospital practice Michael Traynor, Jacob Torrison, Faculty: Hallanger-Johnson JE, Newman DW, and Beal JR PURPOSE: To assess the performance
More informationDepartment of Surgery, Gachon University Gil Hospital, Gachon University of Medicine and Science, Incheon, Departments of
J Korean Surg Soc 2011;81:75-84 DOI: 10.4174/jkss.2011.81.2.75 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Review of atypical cytology of thyroid nodule
More informationThe Bethesda system for reporting thyroid cytopathology: Should Sri Lanka adopt it?
The Bethesda system for reporting thyroid cytopathology: Should Sri Lanka adopt it? Professor. Chandu de Silva Chair and Senior Professor of Pathology Department of Pathology, Faculty of Medicine, University
More informationThyroid nodules are a common clinical presentation, with
Original Research Endocrine Surgery Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade Otolaryngology Head and Neck Surgery
More informationSPECIMEN PREPARATION AND ADEQUACY OF THE MATERIAL
SPECIMEN PREPARATION AND ADEQUACY OF THE MATERIAL Guido FADDA, MD, MIAC Head, Cytopathology Section Department of Anatomic Pathology and Laboratory Medicine Agostino Gemelli School of Medicine and Hospital
More informationSalivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions
Salivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions W.C. Faquin, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School, USA Marc Pusztaszeri,
More informationA Cytohistological Correlation in Thyroid Swelling with Special Reference to The Bethesda System: A Study of 192 Cases.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. XI (Oct. 2017), PP 55-59 www.iosrjournals.org A Cytohistological Correlation in Thyroid
More informationDownloaded from by John Hanna on 11/09/15 from IP address Copyright ARRS. For personal use only; all rights reserved
Neuroradiology/Head and Neck Imaging Original Research Zhu et al. Ultrasound Versus Afirma Testing of FNA-Indeterminate Thyroid Nodules Neuroradiology/Head and Neck Imaging Original Research Qing-Li Zhu
More informationFine-needle aspiration biopsy (FNAB) of the thyroid gland currently
CANCER CYTOPATHOLOGY 179 Cytologic Artifacts and Pitfalls of Thyroid Fine-Needle Aspiration Using ThinPrep A Comparative Retrospective Review Alaa M. Afify, M.D. Jing Liu, M.D. Basim M. Al-Khafaji, M.D.
More informationThe Bethesda System for Reporting Thyroid Cytopathology
AJCP / Special Article The Bethesda System for Reporting Thyroid Cytopathology Edmund S. Cibas, MD, 1 and Syed Z. Ali, MD 2 Key Words: Thyroid; Cytology; Fine-needle aspiration; Terminology Abstract To
More informationFine Needle Aspiration Cytology of Thyroid Follicular Neoplasm: Cytohistologic Correlation and Accuracy
The Korean Journal of Pathology 2013; 47: 61-66 ORIGINAL ARTICLE Fine Needle Aspiration Cytology of Thyroid Follicular Neoplasm: Cytohistologic Correlation and Accuracy Changyoung Yoo Hyun Joo Choi Soyoung
More informationOverview of Indeterminate Cytology
83 rd Annual Meeting American Thyroid Association Overview of Indeterminate Cytology Scott Boerner MD FRCPC Head Cytopathology, University Health Network University of Toronto DISCLOSURE Nothing to disclose
More informationBarriers to the Recognition of Medullary Thyroid Carcinoma on FNA: Implications Relevant to the New American Thyroid Association Guidelines
Barriers to the Recognition of Medullary Thyroid Carcinoma on FNA: Implications Relevant to the New American Thyroid Association Guidelines Kathryn S. Dyhdalo, MD and Deborah J. Chute, MD BACKGROUND: The
More informationSuspicious Cytologic Diagnostic Category in Endoscopic Ultrasound-Guided FNA of the Pancreas: Follow-Up and Outcomes
Suspicious Cytologic Diagnostic Category in Endoscopic Ultrasound-Guided FNA of the Pancreas: Follow-Up and Outcomes Evan A. Alston, MD 1 ; Sejong Bae, PhD 2 ; and Isam A. Eltoum, MD, MBA 1 BACKGROUND:
More informationHEAD AND NECK ENDOCRINE SURGERY
HEAD AND NECK ENDOCRINE SURGERY OCTOBER 22-23, 2010 THE MARK HOPKINS SAN FRANCISCO, CA THYROID FNA AND CYTOPATHOLOGY THEODORE R. MILLER, MD THE THYROID NODULE Prevalence of palpable nodule: Female ~ 6%
More informationASCP Competency Assessment
ASCP Competency Assessment Thyroid Cytopathology Ricardo R. Lastra, MD Michelle R. Pramick, MD Zubair W. Baloch, MD, PhD Department of Pathology & Laboratory Medicine University of Pennsylvania, Perelman
More informationThyroid Pathology: It starts and ends with the gross. Causes of Thyrophobia. Agenda. Diagnostic ambiguity. Treatment/prognosis disconnect
Thyroid Pathology: It starts and ends with the gross Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for
More informationNoninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan
2017, 64 (12), 1149-1155 Original Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan Mitsuyoshi Hirokawa 1), Miyoko Higuchi 2), Ayana
More informationMorphometric Analysis of Thyroid Follicular Cells with Atypia of Undetermined Significance
Journal of Pathology and Translational Medicine 2016; 50: 287-293 ORIGINAL ARTICLE Morphometric Analysis of Thyroid Follicular Cells with Atypia of Undetermined Significance Youngjin Kang Yoo Jin Lee Jiyoon
More information5/3/2017. Ahn et al N Engl J Med 2014; 371
Alan Failor, M.D. Clinical Professor of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington April 20, 2017 No disclosures to report 1. Appropriately evaluate s in adult
More informationThyroid Nodules. Family Medicine Refresher Course Geeta Lal MD, FACS April 2, No financial disclosures
Thyroid Nodules Family Medicine Refresher Course Geeta Lal MD, FACS April 2, 2014 No financial disclosures Objectives Review epidemiology Work up of Thyroid nodules Indications for FNAB Evolving role of
More informationTHE CONTRIBUTION OF CLINICAL AND RADIOLOGICAL FEATURES TO THE DIAGNOSIS IN AUS/FLUS AND FN/SFN THYROID NODULES
Acta Medica Mediterranea, 2016, 32: 151 THE CONTRIBUTION OF CLINICAL AND RADIOLOGICAL FEATURES TO THE DIAGNOSIS IN AUS/FLUS AND FN/SFN THYROID NODULES LUTFI DOGAN*, MEHMET ALI GULCELIK*, NIYAZI KARAMAN*,
More informationLet s Make Sense of Present & Predict Future. In Light of Past 1/12/2016
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Affects on Reporting of Thyroid Fine Needle Aspiration Specimens Deliberations, Criticisms & Discussions Zubair W. Baloch, MD, PhD. Professor
More informationClinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease
Clinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease Robert L. Ferris, MD, PhD Department of Otolaryngology/Head and Neck Surgery and Yuri E. Nikiforov, MD, PhD Division of
More informationCYTOPATHOLOGY OF FOLLICULAR CELL NODULES
104 th Annual USCAP Meeting Boston, March 21-27, 2015 Endocrine Pathology Society. March 21, 2015 Follicular cell-derived tumors of the thyroid gland, a practical update CYTOPATHOLOGY OF FOLLICULAR CELL
More informationMedullary Thyroid Carcinoma. This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands
Medullary Thyroid Carcinoma This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands ADS-01504 Rev. 001 2016 Hologic, Inc. All rights reserved. Overview Medullary Thyroid Carcinoma
More informationExperience With Standardized Thyroid Fine-Needle Aspiration Reporting Categories
Experience With Standardized Thyroid Fine-Needle Aspiration Reporting Categories Follow-Up Data From 529 Cases With Indeterminate or Atypical Reports Min-En Nga, MD 1 ; Marian P. Kumarasinghe, MD 2 ; Bibiana
More informationMaterials and Methods
The Clinical and Diagnostic Impact of Using Standard Criteria of Adequacy Assessment and Diagnostic Terminology on Thyroid Nodule Fine Needle Aspiration Xin Jing, M.D., Claire W. Michael, M.D., and Robert
More informationPathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean. Endocrine Pathology Thyroid Core Needle Biopsy Study Group
Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group Chan Kwon Jung 1 Hye Sook Min 2,3 Hyo Jin Park 2 Dong Eun Song 4 Jang
More informationRelationship of Cytological with Histopathological Examination of Palpable Thyroid Nodule
Relationship of Cytological with Histopathological Examination of Palpable Thyroid Nodule NAUSHEEN HENNA 1, SHAHZAD AHMED FAKHAR 2, NAVEED AKHTER 3, MUHAMMAD MASOOD AFZAL 4, KHIZER AFTAB AHMAD KHAN 5,
More informationThe Bethesda Indeterminate Categories: An Update to Diagnosis and Molecular Testing
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director, Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital The Bethesda Indeterminate Categories:
More information8 Classifying Your Thyroid FNA Specimens Using Bethesda Terminology: Use of Adjunct Molecular Reflex Testing
8 Classifying Your Thyroid FNA Specimens Using Bethesda Terminology: Use of Adjunct Molecular Reflex Testing Constantine Theoharis MD, FASCP David Chhieng MD, FASCP 2011 Annual Meeting Las Vegas, NV AMERICAN
More informationRole of fine needle aspiration cytology and cytohistopathological co-relation in thyroid lesions: experience at a tertiary care centre of North India
International Journal of Research in Medical Sciences Chandra S et al. Int J Res Med Sci. 2016 Oct;4(10):4552-4556 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163328
More informationAn Alphabet Soup of Thyroid Neoplasms
Overall Objectives An Alphabet Soup of Thyroid Neoplasms Lester D. R. Thompson www.lester-thompson.com What is the current management of papillary carcinoma? What are the trends and what can we do differently?
More informationCytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP
Endocrine Journal 2012, 59 (6), 483-487 Or i g i n a l Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP Keiko Nishigami 1), Zhiyan
More informationISSN X (Print) *Corresponding author Dr. Yasmeen Khatib
Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2016; 4(3D):916-923 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)
More informationScholars Academic Journal of Biosciences (SAJB)
Scholars Academic Journal of Biosciences (SAJB) Abbreviated Key Title: Sch. Acad. J. Biosci. Scholars Academic and Scientific Publisher A Unit of Scholars Academic and Scientific Society, India www.saspublisher.com
More informationACCME/Disclosures. Questions to Myself? 4/11/2016
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Affects on Reporting of Thyroid Fine-Needle Aspiration Specimens Deliberations, Criticisms & Discussions Zubair W. Baloch, MD, PhD. Professor
More informationFollicular Derived Thyroid Tumors
Follicular Derived Thyroid Tumors Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences
More informationCan Color Doppler Sonography Aid in the Prediction of Malignancy of Thyroid Nodules?
Article Can Color Doppler Sonography Aid in the Prediction of Malignancy of Thyroid Nodules? Mary C. Frates, MD, Carol B. Benson, MD, Peter M. Doubilet, MD, PhD, Edmund S. Cibas, MD, Ellen Marqusee, MD
More informationThyroid nodules are common clinical findings, with a
Fine-Needle Aspiration Versus Frozen Section in the Evaluation of Malignant Thyroid Nodules in Patients With the Diagnosis of Suspicious for Malignancy or Malignancy by Fine-Needle Aspiration Qin Ye, MD;
More informationAccepted 18 December 2009 Published online 25 May 2010 in Wiley Online Library (wileyonlinelibrary.com). DOI: /hed.21373
ORIGINAL ARTICLE DIMINISHING DIAGNOSIS OF FOLLICULAR THYROID CARCINOMA Kristen J. Otto, MD, 1 Jacqueline S. C. Lam, MBBS, 2 Christina MacMillan, MD, 3 Jeremy L. Freeman, MD, FRCSC 2 1 Department of Otolaryngology
More informationEvaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada
Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental
More informationThe diagnostic value of fine-needle aspiration cytology in the assessment of thyroid nodules: a retrospective 5-year analysis
The diagnostic value of fine-needle aspiration cytology in the assessment of thyroid nodules: a retrospective 5-year analysis GPS Yeoh, KW Chan Objective. To audit the diagnostic accuracy and value of
More information